No. SB 784
Filed under Healthcare.
Medicaid Coverage of Continuous Glucose Monitors; Requiring the Agency for Health Care Administration, within a specified timeframe, to seek federal approval as needed to provide coverage of continuous glucose monitors and related supplies as a durable medical equipment benefit under the Medicaid program; providing for the reimbursement of such equipment, etc.
Plain English Summary
AI-GENERATEDWithin 30 days of becoming law, AHCA must seek federal approval to cover continuous glucose monitors and related supplies as a Medicaid durable medical equipment benefit, typically for people managing diabetes.
Durable medical equipment providers must be reimbursed for these devices once they bill through the standard Medicare coding system, and the agency cannot force them to also supply a drug code number.
Actual coverage does not begin the moment the act becomes law -- the agency must wait until it receives whatever federal approval turns out to be necessary before implementing the benefit.
AIWithin 30 days after the act becomes law, AHCA must seek federal approval, through a Medicaid waiver or state plan amendment, to cover continuous glucose monitors and related supplies as a durable medical equipment benefit for Medicaid recipients.
AIA licensed durable medical equipment provider must be paid for continuous glucose monitors and related supplies once the claim is submitted through the Medicare Healthcare Common Procedure Coding System.
AIThe agency cannot make a durable medical equipment provider include a National Drug Code number when submitting a reimbursement claim for continuous glucose monitors.
AICreating this durable medical equipment benefit does not stop the agency from also covering continuous glucose monitors through the separate Medicaid pharmacy benefit.
AIEven though the act takes effect immediately upon becoming law, the agency does not have to begin covering continuous glucose monitors until it actually receives the necessary federal approval.